Dendritic cell (DC) development begins in the bone marrow but is not completed until after immature progenitors reach their sites of residence in lymphoid organs. The hematopoietic growth factors regulating these processes are poorly understood. Here we examined the effects of signaling by the receptor tyrosine kinase Flt3 on macrophage DC progenitors in the bone marrow and on peripheral DCs. We found that the macrophage DC progenitor compartment was responsive to superphysiological amounts of Flt3 ligand but was not dependent on Flt3 for its homeostatic maintenance in vivo. In contrast, Flt3 was essential to the regulation of homeostatic DC development in the spleen, where it was needed to maintain normal numbers of DCs by controlling their division in the periphery.
Dendritic cell (DC) development begins in the bone marrow but is not completed until after immature progenitors reach their sites of residence in lymphoid organs. The hematopoietic growth factors regulating these processes are poorly understood. Here we examined the effects of signaling by the receptor tyrosine kinase Flt3 on macrophage DC progenitors in the bone marrow and on peripheral DCs. We found that the macrophage DC progenitor compartment was responsive to superphysiological amounts of Flt3 ligand but was not dependent on Flt3 for its homeostatic maintenance in vivo. In contrast, Flt3 was essential to the regulation of homeostatic DC development in the spleen, where it was needed to maintain normal numbers of DCs by controlling their division in the periphery.
Dendritic cells (DCs) are a heterogenous group of specialized antigenpresenting cells that maintain peripheral tolerance and induce adaptive immune responses 1, 2 . Three main groups of DCs have been defined: antigen-presenting conventional DCs (cDCs), found in lymphoid organs such as the spleen; type I interferon-secreting plasmacytoid DCs (pDCs); and migratory DC (mDCs), such as epidermal Langerhans cells or dermal DCs, which capture antigens and deliver them to T cells in lymphoid organs 3, 4 . The cDCs, some tissue macrophages and monocytes originate from a common precursor called the 'macrophage DC progenitor' (MDP) 5, 6 . A common DC precursor (CDP) restricted to cDC and pDC development has been identified, but the macrophage potential of CDPs and their precise relationship to MDPs have not been determined 7, 8 . Nevertheless, MDPs, CDPs or their progeny enter the circulation and are rapidly cleared by migration into lymphoid tissues, where they undergo a limited number of cell divisions while differentiating into DCs 9 . DC proliferation in the spleen contributes to maintaining the size of the peripheral DC pool and can also prolong antigen presentation [9] [10] [11] . Little is known about how DC proliferation in the periphery is regulated, and among the known DC growth factors, only lymphotoxin-b has been linked to helping to maintain CD8 -cDC homeostasis by regulating cell division in the periphery 10 .
The receptor tyrosine kinase Flt3 (also called Flk2 and CD135; A000949) is broadly expressed on early hematopoietic precursors in the bone marrow 12 . Consistent with that expression pattern, injection of Flt3 ligand (Flt3L; also called Flk2L) increases the number of early myeloid and lymphoid progenitors but not committed T cell or B cell precursors, and this is accompanied by increases in the number of peripheral DCs 13, 14 , granulocytes, monocytes and polymorphonuclear neutrophils (PMNs), which leads to the conclusion that the effect of Flt3L is restricted to the bone marrow 12 . In addition, inhibition of Flt3-mediated signals results in fewer peripheral DCs 15, 16 . However, the addition of Flt3L to cultured DC precursors has only modest effects on their proliferative expansion, and the effect of Flt3L on DC precursors and peripheral DCs has not been examined in vivo 5, 7, 8 . Here we report on the function of Flt3 in DC development in the bone marrow and in peripheral lymphoid organs and show that it is an important regulator of homeostatic DC division in the periphery in vivo.
for colony-stimulating factor 1 (CSF1R) and analyzed their developmental potential in vitro and in vivo (Fig. 1) .
We found that about 8% of all Lin -Sca-1 -cells expressed CSF1R in the bone marrow (absolute numbers, 7.2 Â 10 4 ± 0.3 Â 10 4 per two femurs; n ¼ 7 mice; Fig. 1a ). This fraction was rapidly proliferating (35% ± 4% in S or G2 phase; n ¼ 4 mice; Supplementary Fig. 1 online) and did not include early self-renewing hematopoietic precursors (Sca-1 + cells; Fig. 1a) . Lin -CSF1R + cells responded to granulocyte-macrophage colony-stimulating factor (GM-CSF) in vitro by giving rise to DCs, which were Gr-1 -MHCII + CD11c + or Gr-1 -MHCII + CD11c -( Supplementary Fig. 2 online) but failed to respond to CSF1 or to erythropoietin with or without interleukin 3 (IL-3; Fig. 1b) . Although most cells in the cultures treated with GM-CSF were DCs, there was little expansion (threefold), which indicated that this progenitor population undergoes only a limited number of cell divisions before differentiation in response to GM-CSF (Lin -cKit + CSF1R -cells expanded 18-fold). Consistent with published work 7 , in vitro colony formation from single cells in response to Flt3L was undetectable (Fig. 1b) . We conclude that Lin -CSF1R + cell populations are devoid of early and late erythroid progenitor cells and they produce DCs in response to GM-CSF in vitro. In contrast, Lin -CSF1R -cells responded to GM-CSF in vitro by giving rise to cells with diverse phenotypes (Fig. 1b and Supplementary Fig. 2) .
In adoptive transfer experiments, purified Lin -CSF1R + cells (Supplementary Fig. 3 online) gave rise exclusively to spleen CD8 + CD8 -cDCs and SIGNR1 + marginal zone macrophages but not to pDCs, PMNs, red pulp macrophages (F4/80 + ) or metallophilic macrophages (Ser-4 + ), regardless of c-Kit expression ( Fig. 1c and Supplementary Fig. 4 online). In contrast, Lin -c-Kit + CSF1R -cells gave rise to all other myeloid cell types (data not shown). We detected no donor-derived cells in the bone marrow of recipients (data not shown), which suggested that Lin -CSF1R + cells cannot migrate back to their site of origin. MDPs were originally defined as Lin -cells expressing a CX3CR1 promoter-driven GFP transgene, c-Kit 5 and CSF1R 6 (Fig. 1d) . Lin -CX3CR1 + cells included c-Kit + and c-Kitcells and both populations had identical DC potential in adoptive transfer experiments in vivo (Fig. 1e) ; thus, Lin -CX3CR1 + c-Kit + and Lin -CX3CR1 + c-Kit -cells were MDPs (Fig. 1e) . Only 44% of Lin -CX3CR1 + cells expressed CSF1R (21% c-Kit + and 23% c-Kit -; Fig. 1d ), but all Lin -CSF1R + cells were CX3CR1 + (data not shown). We found that 75% of Lin -CSF1R + cells (36% c-Kit + and 39% c-Kit -) expressed Flt3 ( Fig. 1d) and, when separated on the basis of Flt3 expression, cDC progenitor potential was 'concentrated' in Flt3 + cells in vivo (data not shown). Lin -CSF1R + Flt3 -cells failed to give rise to any other cell type (data not shown). CDPs 7 (Lin -c-Kit int Flt3 + CSF1R + ) represented less than 39% of Lin -CSF1R + cells and they are therefore included in MDPs (Fig. 1d) . We conclude that bone marrow-derived Lin -CSF1R + cells give rise to cDCs in vivo and that for analysis of Flt3-mutant mice (discussed below), the Lin -CSF1R + phenotype is sufficient to define MDPs.
Granulocyte-monocyte progenitors (GMPs), common myeloid progenitors (CMPs) and common lymphoid progenitors all have cDC progenitor activity [17] [18] [19] . To determine how MDPs relate to those other progenitor fractions, we analyzed the expression of CD34 and the transmembrane receptor FcgRII/III (CD16/32) by Lin -c-Kit + CX3CR1 + (ref. 5) and Lin -CSF1R + MDPs ( Supplementary Fig. 5 online). We found that the expression profiles of both sets of MDPs overlapped those of GMPs and CMPs and, because of the restricted in vivo developmental potential of MDPs, we conclude that GMPs and CMPs are mixed progenitor populations that contain MDPs 19 .
Effects of Flt3L on MDPs
To determine how Flt3L affects DC development, we examined the effects of its administration on bone marrow and peripheral DCs. After administration of Flt3L, the expression of its receptor, Flt3, was downregulated on MDPs and on spleen cDCs, which indicated a rapid response to Flt3L in all DC compartments (Fig. 2a and data not shown). MDPs (Lin -CSF1R + ; Fig. 2b ) and Lin -c-Kit + CX3CR1 + cells in mice transgenic for the CX3CR1 promoter-driven GFP transgene ( Supplementary Fig. 6 online) were higher by a factor of about ten, whereas GMPs and CMPs were higher by a factor of only about five, and megakaryocytic and erythroid-prone progenitor cells were unaffected 12 ( Supplementary Figs. 6 and 7 online) . However, treatment with Flt3L did not alter the developmental potential of MDPs on a 'per-cell' basis, as shown by adoptive transfer experiments in which MDPs from untreated and Flt3L-treated mice had the same ability to give rise to cDCs (Fig. 2c) . We conclude that Flt3L increases the number of MDPs but does not alter their ability to give rise to DCs.
In the spleen, absolute numbers of cDCs, pDCs, PMNs, monocytes and red pulp macrophages were increased in response to Flt3L (Fig. 2a,b) . To determine whether Flt3L injection also altered the number of DC precursors in the spleen, we did adoptive transfer experiments with mixtures of untreated and Flt3L-treated splenocyte populations depleted of DCs (Fig. 2d) . Because the donor populations were depleted of DCs, newly generated cDCs developed from intrasplenic precursors. The relative increase in DCs from the Flt3L-treated spleens suggested that DC progenitors were mobilized to the spleen in Flt3L-treated mice (Fig. 2d) .
Fewer cDCs and pDCs in Flt3 -/-mice To further investigate the function of Flt3 in DC development, we examined Flt3-deficient mice (Flt3 -/-mice 17 ; Fig. 3 ). The absence of Flt3 led to fewer pDCs (Fig. 3a,b) and cDCs (Fig. 3c) , which was more notable in younger mice 20, 21 , but MDP numbers (Fig. 3j) and spleen pre-cDC numbers 22 ( Fig. 3h and Supplementary Fig. 7 ) remained unaltered. The finding of fewer cDCs and pDCs was not due to a general defect in myeloid cells, as monocyte, PMN, Ser-4 + metallophilic macrophage and SIGNR1 + marginal zone macrophage numbers were not significantly altered (Fig. 3d-f and Supplementary Fig. 8  online) . Unexpectedly, we found that double-mutant mice lacking Flt3 and the GM-CSF receptor did not have a further diminution in pDCs or cDCs ( Supplementary Fig. 9 online) . Thus, the GM-CSF receptor is not required for DC development in vivo, even in the absence of Flt3. We conclude that there is a specific DC defect in the spleens of Flt3 -/-mice.
Flt3 in DC homeostasis
To determine whether the DC defect in Flt3 -/-mice was cell intrinsic, we created bone marrow chimeras by engrafting wild-type mice with Flt3 -/-or wild-type cells and analyzed the recipient mice 4 months later (Fig. 4a) . Recipients had similar engraftment of Flt3 -/-and wildtype hematopoietic stem cells (HSCs), as determined by flow cytometry (Lin -c-Kit + Sca-1 + cells; data not shown), and had similar numbers of PMNs, red pulp macrophages and monocytes but fewer Flt3 -/-pDCs and cDCs (Fig. 4a) . We conclude that the DC deficiency in Flt3 -/-mice was cell intrinsic.
To directly compare the developmental potential of mutant and wild-type progenitors, we constructed mixed bone marrow chimeras and analyzed them after 1.5 months (Fig. 4b and Supplementary  Fig. 10 online) . In the bone marrow, there was similar reconstitution of HSCs and MDPs, and in the periphery, PMN and monocyte reconstitution was 47% and 37%, respectively (Fig. 4b) . In contrast, the contribution of Flt3 -/-cells to both subsets of DCs, red pulp macrophages and, as reported before, T lymphocytes and B lymphocytes 23 was very low, which indicated specific defects in the generation of these lineages in the absence of Flt3 (Fig. 4b) . The defects in DCs were more notable than those of MDPs, which suggested the existence of a Flt3-dependent checkpoint for DC development beyond the MDP stage (Fig. 4b) .
To further investigate the possible involvement of Flt3 in peripheral DC homeostasis, we connected Flt3 -/-mice with wild-type mice by parabiosis and compared them with congenic wild-type mice connected by parabiosis (control mice; Fig. 4c and Supplementary  Fig. 11 online) . In contrast to control mice, only 2% of the cDCs in the spleen of each wild-type parabiotic partner were of Flt3 -/-origin and a disproportionately large number of wild-type cDCs were present in the Flt3 -/-spleen relative to that in wild-type versus wild-type controls (wild-type-wild-type, 15%; wild-type-Flt3 -/-, 64%; Fig. 4c and Supplementary Fig. 11 ). To determine whether the imbalance in Flt3 -/-versus wild-type parabiotic mice was due to lower DC progenitor potential or fewer progenitors, we transplanted a mixture of purified MDPs from wild-type and Flt3 -/-mice into irradiated recipients. At 11 d after transfer, most cDCs were of wild-type origin, which suggested that Flt3 -/-MDPs had less potential to develop into cDCs (Fig. 5a) . The contribution of Flt3 -/-cells was significantly lower after transfer into wild-type mice. To determine whether the difference in DC differentiation potential of wild-type and Flt3 -/-MDPs was Flt3L dependent, we transferred the mixture of the two types of MDPs into Flt3l -/-mice. In contrast to results obtained with wild-type recipients, the ratio of wild-type and Flt3 -/-cDCs in the spleens of Flt3l -/-recipients reflected the input ratio of MDPs (Fig. 5a) . We obtained the same result by transplanting peripheral blood cell populations containing circulating cDC precursors (Fig. 5a) . Thus, in the absence of Flt3L, wild-type and mutant MDPs and peripheral blood-resident cDC precursors had the same potential to develop into cDCs. We conclude that Flt3 is an important mediator of DC development after the MDP and circulating cDC precursor stage.
To analyze the proliferation of Flt3-deficient and Flt3-sufficient cells in the same microenvironment, we generated bone marrow chimeras and measured incorporation of the thymidine analog BrdU into MDPs and cDCs after a pulse of 2 h (Fig. 5b,c) . There was no difference in BrdU uptake in MDPs derived from wild-type or Flt3 -/-HSCs, which confirmed the Flt3-independent generation. In contrast, Flt3 -/-cDCs incorporated less BrdU than did Flt3 +/+ cDCs (Fig. 5b,c) , which suggested that in situ cDC proliferation depended on Flt3. After a BrdU pulse of 4 d, Flt3 -/-cDCs incorporated about 10% less BrdU than wild-type cells did, but pDCs show no difference in BrdU incorporation relative to that of wild-type pDCs (Fig. 5c) , which suggests that a distinct mechanism underlies the paucity of pDCs in Flt3 -/-mice.
To determine whether a defect in cell division in the periphery contributed to the DC defect in the absence of Flt3, we labeled Flt3 -/-and wild-type MDPs with the cytosolic dye CFSE, transferred mixtures of the labeled cells into irradiated recipients and measured cell division by CFSE dilution. We found that Flt3 -/-cells divided less than wildtype cells did in the spleen (Fig. 5d) , which suggested that Flt3 regulates DC cell division in the periphery. To examine the effects of Flt3 on peripheral DC division directly, we injected CFSE-labeled spleen and lymph node cells into unirradiated wild-type and Flt3l -/-mice and measured cDC proliferation by CFSE dilution. We readily detected DC proliferation in wild-type mice, but it was difficult to document in Flt3l -/-recipients (Fig. 5e) . We conclude that Flt3 regulates DC division in the periphery in the steady state.
DISCUSSION
We have shown here that mice deficient in Flt3 had abnormalities in lymphoid tissue-resident cDCs and pDCs. The effects of Flt3 deficiency were most evident in the periphery, where this receptor is essential for the homeostatic expansion of DC progenitor populations in lymphoid organs. In contrast to migratory DCs such as Langerhans cells, which are derived from Gr-1 + monocytes 24 , lymphoid tissueresident cDCs are derived from hematopoietic precursors, which have been called MDPs or CDPs 5, 7, 8 . MDPs were initially defined by expression of a CX3CR1-driven GFP transgene and could only be studied in mice bearing this marker 5 . We have established here that MDPs can also be identified by expression of CSF1R and an absence of lineage markers, including CD11c and CD11b (Lin -CSF1R + ). MDPs were rapidly dividing cells found exclusively in the bone marrow multipotent progenitor compartment (Sca-1 -) and made up to 0.2% of the nucleated cells in the marrow. We found that they were restricted to the bone marrow, which suggested that they are a noncirculating population, a finding also supported by the lack of transfer in mice connected by parabiosis. The original Lin -cKit + CX3CR1 + MDPs include Lin -CSF1R + MDPs, and these have equivalent developmental potential in vivo. However, Lin -CSF1R + MDPs include c-Kit + and c-Kit -cells, which have identical differentiation potential. Despite their homogenous expression of CSF1R, MDPs such as CDPs fail to proliferate in response to CSF1 in vitro, which may be secondary to their isolation with antibody to CSF1R (anti-CSF1R) 7 . In vivo, MDP are developmentally restricted in that they do not give rise to granulocytes, erythroid cells, pDCs, red pulp (F4/80 + ) macrophages or metallophilic (Ser-4 + ) macrophages, but they do have the potential to produce cDCs and SIGNR1 + marginal zone macrophages when injected intravenously. CDPs are Lin -CSF1R + cells that are further defined by being c-Kit int Flt3 + . These cells constitute a fraction of the MDPs. In contrast to MDPs 5 (and described here), CDPs give rise to cDCs and pDCs in vivo 7 . However, CDP-derived pDCs constituted small numbers of graft-derived cells, which were increased by treatment of the recipients with Flt3L 7 . We failed to detect MDP-derived pDCs over 0.6% (± 0.9%; n ¼ 20) after injection into irradiated recipients, but this may have been because of the fractional contribution of CDPs to the overall number of MDPs. Moreover, in our experiments, the presence of small numbers of PDCA1 + cells was always accompanied by the presence of small numbers of PMNs (1.3% ± 3.5%; n ¼ 20), a cell type not analyzed in previously published studies, which suggested the alternative possibility that CDP populations were contaminated with small numbers of multipotent progenitors. Thus, we conclude that the developmental potential of MDPs is restricted to cDCs and marginal zone macrophages. We found that, like CDPs, MDPs expressed Flt3 and that c-Kit seemed to be dispensable for MDP isolation. In conclusion, CDPs overlap Lin -CSF1R + MDPs, as do GMPs and CMPs, which may account for the observation that DC progenitors are found in both of these hematopoietic precursor populations [17] [18] [19] 25 .
Like many other hematopoietic progenitors in the bone marrow, including short-term reconstituting HSCs, common lymphoid progenitors, CMPs and GMPs MDPs express Flt3 (refs.12, 26, 27) . All these cell populations expand in response to exogenous Flt3L, but we found that the effects of Flt3L were greater on MDPs than on any other defined progenitor 12, 28 . Nevertheless, deletion of Flt3L has only modest effects on bone marrow cellularity and does not alter the relative frequency of myeloid progenitors 27, 29 . The only prominent hematopoietic developmental defect in Flt3l -/-mice is in the development of pro-B cells and pre-B cells 29 . Flt3 deletion has even milder effects with no substantial alteration in bone marrow cellularity, but Flt3 -/-progenitors are less able to competitively reconstitute the T cell and myeloid cell lineages in mixed bone marrow adoptive transfer experiments 23 . Consistent with those findings, Flt3L alone is not sufficient to support robust growth of MDPs in vitro 5, 7 and the number of MDPs were unaffected by the absence of Flt3. Thus, the MDP compartment is enlarged in response to superphysiological amounts of Flt3L, but its maintenance is independent of Flt3 in vivo.
Small number of DC progenitors rapidly transit from bone marrow to spleen and lymph nodes through the blood as relatively immature progenitors that do not express surface major histocompatibility complex class II or CD11c 30 . These cells undergo several rounds of cell division while differentiating into cDCs that continue to express Flt3 (refs. 9, 10, 12, 15) . The inhibition of Flt3-mediated signals results in fewer DCs in vivo, possibly because of more apoptosis 16 .
DC division in lymphoid organs is limited, and the peripheral cDC compartment must be continually replenished from blood-borne precursors 9 . DC homeostasis in peripheral lymphoid organs is therefore dependent on the rate of DC progenitor input from blood, cell division and cell death 9 . Our experiments have shown that Flt3L can regulate two aspects of peripheral DC homeostasis: progenitor migration and cDC division. The enhanced migration of DC progenitors to spleen in response to Flt3L is consistent with enhanced migration of monocyte and PMN progenitors and the expansion of these cell populations in the bone marrow 12, 14 . Little is known about the regulation of cDC division in peripheral lymphoid organs. Among the known DC growth factors, only lymphotoxin-b has been linked to helping maintain the homeostasis of the CD8 -subset of cDCs in spleen by regulating cell division in the periphery 10 . Our adoptive transfer experiments have shown that in the absence of Flt3, cDCs were impaired in their ability to undergo homeostatic division and therefore Flt3 is a pivotal growth factor in maintenance of cDC homeostasis in the periphery in the steady state.
In summary, committed DC progenitors in the bone marrow do not require Flt3-mediated signals for their generation. Instead, they expand their populations and emigrate from the bone marrow in response to superphysiological doses of Flt3L in vivo. In contrast, Flt3
